Previously, the guidelines said the drug must be delivered within three hours of the onset of symptoms. The drug, called tissue plasminogen activator, or tPA, breaks down blood clots in the brain, and ...

(HealthDay News) — More community hospitals are giving tissue plasminogen activator (tPA) medication to stroke victims, improving their chances of survival and recovery, new research indicates. The ...

Confirmation that earlier treatment with thrombolysis in patients with acute ischemic stroke translates into better outcomes has come from a registry study involving almost 60,000 patients. In the ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

November 18, 2010 — About half of stroke patients cannot communicate their body weight (BW), only 1 in 5 relatives are able to provide this information, and a physician's or nurse's visual estimation ...

(HealthDay News) — Endovascular therapy with mechanical thrombectomy in ischemic stroke is superior to standard treatment with tissue plasminogen activator (tPA) for preserving brain function, ...

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both ...

Ischemic stroke, caused by a clot in a blood vessel that cuts off blood flow to the brain, is the most common form of stroke and the second leading cause of death for those over 60. In the United ...

“A major point of debate pertains to an item about bypassing a primary stroke center to transport the patient to a comprehensive stroke center offering mechanical thrombectomy,” said Dr Favate. While ...